Prevention of urinary tract infectious diseases in pregnant women

Urinary tract infections are one of the most common infectious diseases in the world. Pregnancy contributes to both the manifestation and recurrence of urinary tract diseases. Urinary tract infections occur in approximately 2-15% pregnant women and increase the frequency of obstetric complications, such as premature birth and low birth weight.This article pays special attention to the prevention of urinary tract infections in pregnant women. For this purpose, bacteriological examination of urine is recommended in most countries of the world, including European ones, which is also regulated by the order of the Ministry of Health of Ukraine. If asymptomatic bacteriuria is detected, a pregnant woman will be prescribed the so-called antibiotic prophylaxis of urinary tract infections. This publication considers the issue of choosing an antibacterial drug and pays special attention to antibiotic resistance. Urinary tract infections are the most common reason for prescribing antibiotics to pregnant women. The development of antibiotic resistance poses a danger to both the mother and the child. In addition to the development of resistance, problems associated with the use of antimicrobial drugs include patient non-compliance with the treatment regimen, side effects for both the mother and the child, and the overall effectiveness of treatment. All of this potentiates alternative methods of preventing both recurrent bacteriuria and urinary tract infections.The prescription of D-mannose-forming drugs, cranberries, their combination with other uro- or immunoprotective agents is an alternative to a re-prescribed antibiotic in order to prevent the recurrence or in case of persistent bacteriuria and recurrent urinary tract infections, especially if Escherichia coli is isolated from the urine (80-85% of all uropathogens).